H.C. Wainwright analyst Douglas Tsao maintains $Alkermes (ALKS.US)$ with a hold rating, and maintains the target price at $37.
According to TipRanks data, the analyst has a success rate of 45.4% and a total average return of 13.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Alkermes (ALKS.US)$'s main analysts recently are as follows:
Alkermes' recent quarterly performance was consistent with expectations, and the company maintained its outlook for 2024. However, during the earnings discussion, attention was drawn to projections that 2025 EBITDA would exceed $200M, contrasting with a consensus of $400M. This difference in EBITDA expectations seems to stem from the anticipated decline of high-margin royalty incomes and, to a smaller degree, increased expenditure.
Alkermes' Q3 results presented an operating performance in line with expectations, reflecting a mix of positive and negative factors. The company is intensifying its investment focus on ALKS-2680 and its orexin-2 receptor agonist pipeline, which may moderate short-term profitability. Nonetheless, there is optimism regarding the long-term value generation prospects of ALKS-2680.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.